The Safety and Tolerability of Metformin plus Colesevelam in Drug-Naive Patients with Early Type 2 Diabetes Mellitus

被引：0
|
作者：
Abby, Stacey L.
Garvey, W. Timothy
Handelsman, Yehuda
Fonseca, Vivian A.
Goldberg, Ronald B.
Rosenstock, Julio
Jones, Michael R.
Markiewicz, Magdalena
Jin, Xiaoping
Misir, Soamnauth
Nagendran, Sukumar
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A173 / A173
页数：1
相关论文
共 50 条
  • [41] Sustained efficacy and tolerability of vildagliptin monotherapy during one-year treatment of drug-naive patients with type 2 diabetes
    Goekel, B.
    Schweizer, A.
    Couturier, A.
    LeBeaut, A.
    Dejager, S.
    DIABETOLOGIA, 2006, 49 : 28 - 28
  • [42] Association of the SLC47A1 Gene Variant With Responses to Metformin Monotherapy in Drug-naive Patients With Type 2 Diabetes
    Kim, Hamin
    Bae, Suhyun
    Yoon, Ha Young
    Yee, Jeong
    Gwak, Hye Sun
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09): : 2684 - 2690
  • [43] The efficacy of pioglitazone compared to metformin in drug naive patients with type 2 diabetes
    Schernthaner, G
    Edwards, G
    Lee, C
    Tan, M
    Herz, M
    DIABETES, 2003, 52 : A455 - A455
  • [44] A comparative assessment of efficacy and safety of oral antidiabetic drug combinations, metformin plus pioglitazone versus metformin plus glimepiride in type-2 diabetes mellitus
    Biswas, R. K.
    Paul, K.
    Mukherjee, A. K.
    Bhattacherjee, I
    Mondal, S.
    INDIAN JOURNAL OF PHARMACOLOGY, 2008, 40 : 51 - 51
  • [45] Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naive Patients With Type 2 Diabetes
    Rosenstock, Julio
    Inzucchi, Silvio E.
    Seufert, Jochen
    Fleck, Penny R.
    Wilson, Craig A.
    Mekki, Qais
    DIABETES CARE, 2010, 33 (11) : 2406 - 2408
  • [46] Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naive patients with type 2 diabetes: a randomized, double-blind, 6-month study
    Pratley, R. E.
    Fleck, P.
    Wilson, C.
    DIABETES OBESITY & METABOLISM, 2014, 16 (07): : 613 - 621
  • [47] Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes
    Goldfine, A. B.
    Fonseca, V. A.
    Jones, M. R.
    Wang, A. C.
    Ford, D. M.
    Truitt, K. E.
    HORMONE AND METABOLIC RESEARCH, 2010, 42 (01) : 23 - 30
  • [48] Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
    Ona Kinduryte Schorling
    Douglas Clark
    Isabella Zwiener
    Stefan Kaspers
    Jisoo Lee
    Hristo Iliev
    Advances in Therapy, 2020, 37 : 3463 - 3484
  • [49] Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
    Kinduryte Schorling, Ona
    Clark, Douglas
    Zwiener, Isabella
    Kaspers, Stefan
    Lee, Jisoo
    Iliev, Hristo
    ADVANCES IN THERAPY, 2020, 37 (08) : 3463 - 3484
  • [50] Treatment patterns of drug-naive patients with type 2 diabetes mellitus: a retrospective cohort study using a Japanese hospital database
    Morita, Yohei
    Murayama, Hiroki
    Odawara, Masato
    Bauer, Melissa
    DIABETOLOGY & METABOLIC SYNDROME, 2019, 11 (01):
12345